Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $203.72 million. The enterprise value is $248.13 million.
Important Dates
The next confirmed earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 17.70 million shares outstanding. The number of shares has increased by 4.77% in one year.
| Current Share Class | 17.70M |
| Shares Outstanding | 17.70M |
| Shares Change (YoY) | +4.77% |
| Shares Change (QoQ) | +4.44% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 22.12% |
| Float | 14.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | 1.65 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 7.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69, with a Debt / Equity ratio of 7.53.
| Current Ratio | 5.69 |
| Quick Ratio | 4.28 |
| Debt / Equity | 7.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.52 |
Financial Efficiency
Return on equity (ROE) is -170.97% and return on invested capital (ROIC) is -27.63%.
| Return on Equity (ROE) | -170.97% |
| Return on Assets (ROA) | -22.86% |
| Return on Invested Capital (ROIC) | -27.63% |
| Return on Capital Employed (ROCE) | -46.79% |
| Revenue Per Employee | $321,155 |
| Profits Per Employee | -$361,514 |
| Employee Count | 354 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, Outset Medical has paid $491,000 in taxes.
| Income Tax | 491,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.91% in the last 52 weeks. The beta is 1.90, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.90 |
| 52-Week Price Change | -69.91% |
| 50-Day Moving Average | 10.77 |
| 200-Day Moving Average | 16.35 |
| Relative Strength Index (RSI) | 55.10 |
| Average Volume (20 Days) | 141,264 |
Short Selling Information
The latest short interest is 876,793, so 4.95% of the outstanding shares have been sold short.
| Short Interest | 876,793 |
| Short Previous Month | 11.82M |
| Short % of Shares Out | 4.95% |
| Short % of Float | 6.17% |
| Short Ratio (days to cover) | 8.45 |
Income Statement
In the last 12 months, Outset Medical had revenue of $113.69 million and -$127.98 million in losses. Loss per share was -$36.95.
| Revenue | 113.69M |
| Gross Profit | 39.14M |
| Operating Income | -107.82M |
| Pretax Income | -158.67M |
| Net Income | -127.98M |
| EBITDA | -102.09M |
| EBIT | -107.82M |
| Loss Per Share | -$36.95 |
Full Income StatementBalance Sheet
The company has $158.69 million in cash and $201.86 million in debt, giving a net cash position of -$43.17 million or -$2.44 per share.
| Cash & Cash Equivalents | 158.69M |
| Total Debt | 201.86M |
| Net Cash | -43.17M |
| Net Cash Per Share | -$2.44 |
| Equity (Book Value) | 26.82M |
| Book Value Per Share | 7.60 |
| Working Capital | 212.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$116.30 million and capital expenditures -$912,000, giving a free cash flow of -$117.22 million.
| Operating Cash Flow | -116.30M |
| Capital Expenditures | -912,000 |
| Free Cash Flow | -117.22M |
| FCF Per Share | -$6.62 |
Full Cash Flow StatementMargins
Gross margin is 34.43%, with operating and profit margins of -94.84% and -112.57%.
| Gross Margin | 34.43% |
| Operating Margin | -94.84% |
| Pretax Margin | -112.13% |
| Profit Margin | -112.57% |
| EBITDA Margin | -89.80% |
| EBIT Margin | -94.84% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.77% |
| Shareholder Yield | -4.77% |
| Earnings Yield | -62.44% |
| FCF Yield | -57.19% |
Analyst Forecast
The average price target for Outset Medical is $45.00, which is 290.96% higher than the current price. The consensus rating is "Buy".
| Price Target | $45.00 |
| Price Target Difference | 290.96% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 13.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
Outset Medical has an Altman Z-Score of -5.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.19 |
| Piotroski F-Score | 4 |